Security Snapshot

VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) Institutional Ownership

CUSIP: 92189F387

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

141

Shares (Excl. Options)

11,059,705

Price

$22.66

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / SHRT HGH YLD MUN
Symbol
SHYD
Price per share
$22.71
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
11,059,705
Total reported value
$250,616,666
% of total 13F portfolios
0%
Share change
+345,528
Value change
+$7,771,306
Number of holders
141
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SHYD - VANECK ETF TRUST - SHRT HGH YLD MUN is tracked under CUSIP 92189F387.
  • 141 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 145 to 141 between Q4 2025 and Q1 2026.
  • Reported value moved from $250,649,774 to $250,616,666.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 141 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 92189F387?
CUSIP 92189F387 identifies SHYD - VANECK ETF TRUST - SHRT HGH YLD MUN in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

As of 31 Mar 2026, 141 institutional investors reported holding 11,059,705 shares of VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD).

Institutional Holders of VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 11,059,705 $250,616,666 +$7,771,306 $22.66 141
2025 Q4 10,940,561 $250,649,774 +$15,365,780 $22.91 145
2025 Q3 10,199,713 $233,510,155 +$650,034 $22.90 131
2025 Q2 10,126,619 $228,720,824 +$11,154,960 $22.59 129
2025 Q1 9,566,858 $215,125,672 +$6,885,166 $22.49 120
2024 Q4 9,396,480 $211,258,799 +$9,751,547 $22.48 125
2024 Q3 8,909,672 $202,402,767 -$1,053,963 $22.72 116
2024 Q2 8,875,499 $198,528,389 -$7,564,000 $22.37 112
2024 Q1 9,168,215 $205,427,631 -$23,956,421 $22.41 106
2023 Q4 10,278,899 $227,451,634 +$10,405,892 $22.13 119
2023 Q3 9,718,105 $210,090,133 -$1,808,132 $21.62 109
2023 Q2 9,756,447 $217,568,386 +$2,520,488 $22.30 107
2023 Q1 9,623,412 $214,519,159 -$6,636,472 $22.29 110
2022 Q4 9,923,778 $221,171,485 -$5,192,513 $22.27 107
2022 Q3 10,064,832 $219,273,531 -$8,869,906 $21.77 101
2022 Q2 10,421,287 $234,148,365 +$35,389,105 $22.46 102
2022 Q1 8,820,177 $205,232,466 +$13,273,275 $23.26 101
2021 Q4 8,141,253 $204,743,214 -$2,802,724 $25.15 110
2021 Q3 8,148,102 $204,518,481 +$43,370,524 $25.10 98
2021 Q2 6,418,663 $162,311,214 +$28,751,483 $25.45 93
2021 Q1 5,277,974 $132,091,961 +$28,070,512 $25.02 87
2020 Q4 4,152,598 $103,004,254 -$1,697,549 $24.80 73
2020 Q3 4,212,793 $102,677,662 -$11,333,542 $24.38 68
2020 Q2 4,667,416 $111,213,168 -$48,800,573 $23.82 67
2020 Q1 6,496,591 $146,248,835 +$38,177,787 $22.51 71
2019 Q4 5,012,099 $126,326,193 +$22,698,966 $25.20 72
2019 Q3 4,376,431 $110,199,083 +$9,825,487 $25.18 63
2019 Q2 3,953,833 $99,007,328 +$6,629,321 $25.04 60
2019 Q1 3,742,501 $92,440,015 +$17,151,731 $24.70 55
2018 Q4 3,028,375 $73,385,143 -$4,699,882 $24.20 51
2018 Q3 2,875,953 $69,911,719 +$2,042,275 $24.31 48
2018 Q2 2,791,046 $68,420,934 +$18,923,785 $24.52 44
2018 Q1 1,998,408 $48,376,265 +$1,602,184 $24.21 42
2017 Q4 1,932,326 $46,757,129 +$1,860,479 $24.19 39
2017 Q3 1,847,931 $45,198,000 -$1,524,595 $24.46 31
2017 Q2 1,910,512 $46,386,000 -$4,439,837 $24.28 36
2017 Q1 2,094,438 $50,279,000 -$20,757,757 $24.01 34
2016 Q4 2,960,434 $70,417,000 +$9,324,620 $23.79 36
2016 Q3 2,269,302 $57,301,000 +$4,821,082 $25.25 24
2016 Q2 2,139,169 $54,435,000 +$52,772,710 $25.45 28
2016 Q1 61,538 $1,530,000 +$718,000 $24.88 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .